Buprenorphine and Ponesimod: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Ponesimod
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both buprenorphine (a pain and opioid-dependence medicine) and ponesimod (Ponvory, used for multiple sclerosis) can each affect your heart's electrical rhythm in a way called QT prolongation. When two medicines that do this are taken together, the effect can add up and, in rare cases, raise the chance of an abnormal heartbeat.
It's worth knowing this concern comes mostly from how these drugs work in theory, not from lots of real-world reports. Please don't stop or change either medicine on your own. Your care team, sometimes with a heart doctor's input, can check your heart rhythm and manage this safely.
Effect: Additive QT interval prolongation with increased theoretical risk of arrhythmia (including torsades de pointes) when buprenorphine is combined with ponesimod.
Mechanism: Additive pharmacodynamic effect on cardiac repolarization; both agents carry QT-prolonging potential. Neither is a prodrug relevant here, so this is a PD interaction, not a metabolic one.
- Direction/magnitude: Additive; magnitude not quantified.
- Onset: Unspecified.
- Evidence: Theoretical; severity rated major.
- Management: Concurrent use of ponesimod with known arrhythmogenic QT-prolonging drugs is not recommended. If unavoidable, obtain cardiology input beforehand to define appropriate ECG/rhythm monitoring; review electrolytes and other QT-prolonging agents.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Because of possible additive impacts on heart rate, giving ponesimod together with QT prolonging medications that have recognized arrhythmogenic properties is not advised. Should such therapy be contemplated, a cardiologist should be consulted before starting treatment so that the most suitable monitoring can be identified1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
The main tool here is careful monitoring and specialist input, not a fixed dose change.
- Keep taking both medicines exactly as prescribed unless your care team tells you otherwise.
- Because combining ponesimod with a QT-prolonging drug like buprenorphine is generally not recommended, your prescriber may seek advice from a cardiologist before or during treatment to decide on the right heart-rhythm monitoring.
- Tell your pharmacist or doctor about any other medicines you take, since some also affect the QT interval.
- Report symptoms like fainting, palpitations, dizziness, or an irregular heartbeat promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Buprenorphine and Ponesimod together?
Buprenorphine and ponesimod can both prolong the QT interval, so combining them may add up and raise arrhythmia risk; this pairing is generally not recommended, and your team may involve a cardiologist to set up heart monitoring. Keep taking both as prescribed and report fainting or palpitations. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Buprenorphine and Ponesimod interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Buprenorphine and Ponesimod interaction managed?
The main tool here is careful monitoring and specialist input, not a fixed dose change. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Because combining ponesimod with a QT-prolonging drug like buprenorphine is generally not recommended, your prescriber may seek advice from a cardiologist before or during treatment to decide on the right heart-rhythm mo… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Buprenorphine or Ponesimod need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: PONVORY(R) oral tablets, ponesimod oral tablets. Janssen Pharmaceuticals Inc (per FDA), Titusville, NJ, 2024. DailyMed
Keep reading about Buprenorphine
Keep reading about Ponesimod
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist